Connect with us

Health

AstraZeneca’s Farxiga reduces death risk in heart failure patients

Published

on

AstraZeneca’s (AZN.L) blockbuster diabetes drug Farxiga led to significant reductions in the risk of hospitalization and death in people with all types of heart failure, according to study data released on Saturday.

The drug belongs to a class of medicines called SGLT2 inhibitors that were initially approved to treat type 2 diabetes. Since then, the drugs have been shown to benefit patients with chronic kidney and heart disease and prevent heart attacks.

Farxiga is the first heart failure medication to show mortality benefit across all forms of heart failure, the company said as reported by Reuters.

Detailed data from a study called ‘DELIVER’ evaluating Farxiga in patients with a form of heart failure characterized by mildly reduced or preserved ejection fraction was presented at the European Society of Cardiology congress in Barcelona. Ejection fraction measures the heart’s ability to pump oxygen-rich blood into the body.

Farxiga met the study’s primary goal, inducing a statistically significant reduction in the risk of heart-related death, heart failure hospitalization and urgent heart failure visits by 18%.

A pooled analysis of DELIVER and another trial involving about 11,000 heart failure patients combined showed Farxiga reduced the risk of death from cardiovascular causes – including heart attacks – by 14%, and death from any cause by 10%. The drug also cut the risk of hospital admissions for heart failure by close to a third.

Heart failure occurs when the heart muscle becomes unable to pump blood as efficiently as it should, and can cause a range of serious health problems and death. Of the estimated 64 million heart failure patients globally, roughly half have reduced ejection fraction, which is equal to or less than 40%. The remainder have mildly reduced or preserved ejection fraction.

Health

Afghanistan, Uzbekistan move to expand cooperation in pharmaceutical sector

The two sides discussed expanding cooperation in the production and regulation of medicines and health products.

Published

on

Afghanistan’s Ministry of Public Health has announced that Abdul Basir Qane, Director General of Drug and Health Products Regulation at the ministry’s Food and Drug Deputy, held talks with Uzbek health officials during his visit to Uzbekistan to strengthen bilateral cooperation in the pharmaceutical sector.

According to a statement issued by the ministry, Qane and his technical delegation met with Abdullah Azizov, head of Uzbekistan’s regulatory authority for medical and pharmaceutical industries, along with other senior officials.

The two sides discussed expanding cooperation in the production and regulation of medicines and health products, facilitating the entry of Uzbek pharmaceutical manufacturers into the Afghan market, implementing inspections in line with Good Manufacturing Practice (GMP) standards, streamlining the registration process for medicines, and increasing bilateral trade in pharmaceutical products.

The discussions also covered the development of laboratory infrastructure, capacity building and training for specialists, the exchange of expertise in regulatory and inspection fields, and broader technical and professional cooperation between the two countries.

At the conclusion of the meeting, both sides reaffirmed their commitment to strengthening long-term cooperation in the pharmaceutical and health products sector, supporting the activities of pharmaceutical companies in both markets, and continuing dialogue on mutually beneficial joint projects, the ministry said.

Continue Reading

Health

Polio cases in Afghanistan rise to six in 2026 as two new cases confirmed

According to the WHO, one of the newly confirmed cases was identified in Nari district of Kunar province, while the other was reported in Nahr-e-Siraj district of Helmand province.

Published

on

The World Health Organization (WHO) has announced that the number of confirmed polio cases in Afghanistan has risen to six in 2026, following the detection of two new infections in the country.

According to the WHO, one of the newly confirmed cases was identified in Nari district of Kunar province, while the other was reported in Nahr-e-Siraj district of Helmand province. The organization also stated that 34 positive environmental samples of wild poliovirus have been recorded in Afghanistan so far this year.

The report adds that in 2025, a total of 52 wild poliovirus type 1 cases were confirmed across Afghanistan and Pakistan, including 21 cases in Afghanistan and 31 in Pakistan.

WHO further noted that in 2026 so far, nine wild poliovirus type 1 cases have been reported across both countries, with six in Afghanistan and three in Pakistan.

Health experts say that low public awareness, resistance from some families to vaccination campaigns, and limited access to remote areas remain key factors behind the continued spread of the disease.

They emphasize that polio is incurable and vaccination is the only effective way to prevent infection.

Public health specialists also stress the need to expand immunization coverage, particularly in hard-to-reach areas, and to strengthen public awareness campaigns, warning that eradication efforts will remain difficult without broad community cooperation.

Afghanistan and Pakistan remain the only two countries in the world where wild poliovirus is still endemic and has not been fully eradicated.

Continue Reading

Health

Health ministry urges greater public participation in blood donation

The appeal was made on Saturday as health officials marked World Blood Donor Day, an annual event aimed at raising awareness about the importance of voluntary blood donation and recognizing the contribution of donors in saving lives.

Published

on

Afghanistan’s Ministry of Public Health has called on citizens to increase their participation in blood donation campaigns, warning that many patients still struggle to obtain compatible blood in emergencies despite improvements in the country’s blood management system.

The appeal was made on Saturday as health officials marked World Blood Donor Day, an annual event aimed at raising awareness about the importance of voluntary blood donation and recognizing the contribution of donors in saving lives.

Speaking at the ceremony, officials highlighted the critical role blood donors play in supporting the healthcare system and ensuring that hospitals have adequate supplies for patients requiring urgent treatment.

Abdul Wali Haqqani, Deputy Minister for Health Services at the Ministry of Public Health, said that shortages in blood reserves continue to pose challenges for healthcare providers, particularly when patients require specific blood types.

“Unfortunately, patients who need blood do not always have immediate access to compatible negative blood groups,” Haqqani said. “Blood donation is a simple yet invaluable humanitarian act. The World Health Organization recommends that at least one percent of a country’s population donate blood regularly to maintain sufficient reserves.”

Haqqani stressed that increasing public participation in blood donation could significantly improve the availability of life-saving blood supplies and strengthen healthcare services across the country.

Meanwhile, Wahdat Alkozi, Director of Curative Medicine at the ministry, said Afghanistan has made notable progress in blood management in recent years. He noted that standardized blood separation and storage systems are now operating at the Central Blood Bank and several regional hospitals.

“We are working to expand these systems throughout the country so that patients can have greater access to safe and standardized blood services,” Alkozi said.

According to officials from the Central Blood Bank, more than 220,000 units of blood were collected from voluntary donors over the past year. The blood was used in the treatment of more than 250,000 patients nationwide, underscoring the growing demand for blood supplies in hospitals and healthcare facilities.

However, Niazgul Niazmand, head of the Central Blood Bank, said the shortage of negative blood groups remains a major challenge due to the limited number of donors with those blood types.

Health experts emphasize that blood donation not only helps save the lives of accident victims, surgical patients, mothers experiencing childbirth complications, and individuals suffering from serious illnesses, but can also benefit donors by promoting healthy blood circulation and stimulating the production of new blood cells.

World Blood Donor Day is observed every year on June 14 to encourage voluntary blood donation and raise awareness about the ongoing need for safe blood and blood products around the world.

Continue Reading
Advertisement
Advertisement
Advertisement
Advertisement

Trending

Copyright © 2025 Ariana News. All rights reserved!


Warning: Undefined array key "slug" in /var/www/vhosts/ariananews.af/httpdocs/wp-includes/class-wp-theme-json.php on line 2117

Warning: Undefined array key "slug" in /var/www/vhosts/ariananews.af/httpdocs/wp-includes/class-wp-theme-json.php on line 2117

Warning: Undefined array key "slug" in /var/www/vhosts/ariananews.af/httpdocs/wp-includes/class-wp-theme-json.php on line 2117